Production (Stage)
CV Sciences, Inc.
CVSI
$0.035
-$0.0019-5.15%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.16% | 0.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.16% | 0.49% | |||
| Cost of Revenue | -11.74% | 5.75% | |||
| Gross Profit | -1.13% | -5.68% | |||
| SG&A Expenses | 4.09% | 2.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.14% | 3.90% | |||
| Operating Income | 102.73% | -54.41% | |||
| Income Before Tax | 86.22% | -62.28% | |||
| Income Tax Expenses | 150.00% | -- | |||
| Earnings from Continuing Operations | 84.99% | -59.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 84.99% | -59.21% | |||
| EBIT | 102.73% | -54.41% | |||
| EBITDA | 132.18% | -60.56% | |||
| EPS Basic | 84.62% | -56.00% | |||
| Normalized Basic EPS | 70.59% | -30.77% | |||
| EPS Diluted | 84.62% | -56.00% | |||
| Normalized Diluted EPS | 70.59% | -30.77% | |||
| Average Basic Shares Outstanding | -0.03% | 1.13% | |||
| Average Diluted Shares Outstanding | -0.03% | 1.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||